Joseph C. Fleishaker

2.9k total citations
85 papers, 2.1k citations indexed

About

Joseph C. Fleishaker is a scholar working on Psychiatry and Mental health, Pharmacology and Anesthesiology and Pain Medicine. According to data from OpenAlex, Joseph C. Fleishaker has authored 85 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Psychiatry and Mental health, 23 papers in Pharmacology and 16 papers in Anesthesiology and Pain Medicine. Recurrent topics in Joseph C. Fleishaker's work include Treatment of Major Depression (18 papers), Epilepsy research and treatment (16 papers) and Anesthesia and Sedative Agents (16 papers). Joseph C. Fleishaker is often cited by papers focused on Treatment of Major Depression (18 papers), Epilepsy research and treatment (16 papers) and Anesthesia and Sedative Agents (16 papers). Joseph C. Fleishaker collaborates with scholars based in United States, New Zealand and France. Joseph C. Fleishaker's co-authors include Gary Peters, Mihály Hajós, Erik H.F. Wong, Patrick J. McNamara, Laura Pearson, Mark T. Brown, Nirmala S. Desai, J. Paul Phillips, Rick C. Steenwyk and K. S. Cathcart and has published in prestigious journals such as Advanced Drug Delivery Reviews, Antimicrobial Agents and Chemotherapy and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Joseph C. Fleishaker

85 papers receiving 2.0k citations

Peers

Joseph C. Fleishaker
Sheila Dawling United Kingdom
Stephen H. Curry United States
Roberto Goméni Italy
Hermann R. Ochs United States
John‐Michael Sauer United States
Norio Yasui‐Furukori Japan
D.D. Breimer Netherlands
L. F. Gram Denmark
LI Huan-de China
D J Greenblatt United States
Sheila Dawling United Kingdom
Joseph C. Fleishaker
Citations per year, relative to Joseph C. Fleishaker Joseph C. Fleishaker (= 1×) peers Sheila Dawling

Countries citing papers authored by Joseph C. Fleishaker

Since Specialization
Citations

This map shows the geographic impact of Joseph C. Fleishaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph C. Fleishaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph C. Fleishaker more than expected).

Fields of papers citing papers by Joseph C. Fleishaker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph C. Fleishaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph C. Fleishaker. The network helps show where Joseph C. Fleishaker may publish in the future.

Co-authorship network of co-authors of Joseph C. Fleishaker

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph C. Fleishaker. A scholar is included among the top collaborators of Joseph C. Fleishaker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph C. Fleishaker. Joseph C. Fleishaker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fleishaker, Joseph C., et al.. (2005). Clinical Pharmacokinetics of Almotriptan, a Serotonin 5-HT1B/1D Receptor Agonist for the Treatment of Migraine. Clinical Pharmacokinetics. 44(3). 237–246. 27 indexed citations
2.
Fleishaker, Joseph C.. (2003). Models and methods for predicting drug transfer into human milk. Advanced Drug Delivery Reviews. 55(5). 643–652. 66 indexed citations
3.
Sarapa, Nenad, Steven R. Cox, Steven F. Francom, et al.. (2003). Valdecoxib, a COX‐2‐Specific Inhibitor, Does Not Affect Cardiac Repolarization. The Journal of Clinical Pharmacology. 43(9). 974–982. 2 indexed citations
4.
Fleishaker, Joseph C., et al.. (2003). Interaction between Ketoconazole and Almotriptan in Healthy Volunteers. The Journal of Clinical Pharmacology. 43(4). 423–427. 22 indexed citations
5.
Fleishaker, Joseph C., et al.. (2001). Evaluation of the Potential Pharmacokinetic Interaction between Almotriptan and Fluoxetine in Healthy Volunteers. The Journal of Clinical Pharmacology. 41(2). 217–223. 26 indexed citations
6.
Fleishaker, Joseph C., et al.. (2001). Pharmacokinetics of reboxetine in healthy volunteers with different ethnic descents. Psychopharmacology. 155(2). 148–153. 13 indexed citations
7.
Bergmann, Jean‐François, et al.. (2000). Pharmacokinetics of reboxetine in healthy, elderly volunteers. European Journal of Drug Metabolism and Pharmacokinetics. 25(3-4). 195–198. 8 indexed citations
8.
Fleishaker, Joseph C., et al.. (1999). Absolute bioavailability of reboxetine enantiomers and effect of gender on pharmacokinetics. Biopharmaceutics & Drug Disposition. 20(1). 53–57. 33 indexed citations
9.
Fleishaker, Joseph C. & Gary Peters. (1996). Pharmacokinetics of Tirilazad and U‐89678 in Ischemic Stroke Patients Receiving a Loading Regimen and Maintenance Regimen of 10 mg/kg/day of Tirilazad. The Journal of Clinical Pharmacology. 36(9). 809–813. 8 indexed citations
10.
Pearson, Laura, Joseph C. Fleishaker, & Gary Peters. (1996). Comparison of the pharmacokinetics of tirilazad mesylate in healthy volunteers and stable subjects with mild liver cirrhosis. European Journal of Clinical Pharmacology. 50(4). 299–304. 1 indexed citations
11.
Fleishaker, Joseph C., et al.. (1995). Studies with [11C]alprazolam: an agonist for the benzodiazepine receptor. Nuclear Medicine and Biology. 22(4). 459–466. 8 indexed citations
12.
Fleishaker, Joseph C., et al.. (1994). Lack of a Pharmacokinetic/Pharmacodynamic Interaction Between Nimodipine and Tirilazad Mesylate in Healthy Volunteers. The Journal of Clinical Pharmacology. 34(8). 837–841. 5 indexed citations
13.
Fleishaker, Joseph C., et al.. (1994). Lack of pharmacokinetic interaction between cimetidine and tirilazad mesylate.. Pharmaceutical Research. 11(2). 341–344. 3 indexed citations
14.
Fleishaker, Joseph C., et al.. (1994). A pharmacokinetic and pharmacodynamic evaluation of the combined administration of alprazolam and fluvoxamine. European Journal of Clinical Pharmacology. 46(1). 35–9. 115 indexed citations
15.
Fleishaker, Joseph C., et al.. (1993). Psychomotor and Memory Effects of Two Adinazolam Formulations Assessed by a Computerized Neuropsychological Test Battery. The Journal of Clinical Pharmacology. 33(5). 463–469. 7 indexed citations
16.
Fleishaker, Joseph C., Gary Peters, K. S. Cathcart, & Rick C. Steenwyk. (1993). Evaluation of the Pharmacokinetics and Tolerability of Tirilazad Mesylate, a 21‐Aminosteroid Free Radical Scavenger: II. Multiple‐Dose Administration. The Journal of Clinical Pharmacology. 33(2). 182–190. 28 indexed citations
17.
Fleishaker, Joseph C., Thomas C. Smith, H. Friedman, & J. Paul Phillips. (1991). N-desmethyladinazolam pharmacokinetics and behavioral effects following administration of 10–50 mg oral doses in healthy volunteers. Psychopharmacology. 105(2). 181–185. 8 indexed citations
18.
Fleishaker, Joseph C., J. Paul Phillips, & Henry Lau. (1990). Effect of food on the bioavailability of adinazolam from a sustained release formulation: Effect of meal timing and lack of dose dumping. Biopharmaceutics & Drug Disposition. 11(8). 715–727. 6 indexed citations
19.
Fleishaker, Joseph C., J. Paul Phillips, Thomas C. Smith, & Randall B. Smith. (1989). Multiple-dose pharmacokinetics and pharmacodynamics of adinazolam in elderly subjects.. Pharmaceutical Research. 6(5). 379–386. 18 indexed citations
20.
Fleishaker, Joseph C., J. Paul Phillips, Mark G. Eller, & Randall B. Smith. (1989). Pharmacokinetics and Pharmacodynamics of Alprazolam Following Single and Multiple Oral Doses of a Sustained‐Release Formulation. The Journal of Clinical Pharmacology. 29(6). 543–549. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sheila Dawling Breakdown of academic impact, for papers by Stephen H. Curry Breakdown of academic impact, for papers by Roberto Goméni Breakdown of academic impact, for papers by Hermann R. Ochs Breakdown of academic impact, for papers by John‐Michael Sauer Breakdown of academic impact, for papers by Norio Yasui‐Furukori Breakdown of academic impact, for papers by D.D. Breimer Breakdown of academic impact, for papers by L. F. Gram Breakdown of academic impact, for papers by LI Huan-de Breakdown of academic impact, for papers by D J Greenblatt
Rankless by CCL
2026